tiprankstipranks
Trending News
More News >
Pharming Group (PHGUF)
OTHER OTC:PHGUF
US Market

Pharming Group (PHGUF) Financial Statements

Compare
98 Followers

Pharming Group Financial Overview

Pharming Group's market cap is currently $1.43B. The company's EPS TTM is $0.01; its P/E ratio is 1,383.33; Pharming Group is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is
lt;0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 286.89M€ 245.32M€ 205.62M€ 189.85M€ 228.39M
Gross Profit€ 231.82M€ 220.10M€ 188.06M€ 169.67M€ 203.06M
Operating Income€ -3.39M€ -4.88M€ 18.23M€ 27.84M€ 82.09M
EBITDA€ 13.18M€ 9.88M€ 33.53M€ 48.78M€ 92.11M
Net Income€ -10.64M€ -10.55M€ 13.67M€ 16.00M€ 37.75M
Balance Sheet
Cash & Short-Term Investments€ 162.07M€ 213.42M€ 207.34M€ 191.72M€ 205.49M
Total Assets€ 386.88M€ 462.85M€ 425.80M€ 396.90M€ 419.12M
Total Debt€ 108.42M€ 171.54M€ 166.69M€ 161.59M€ 162.22M
Net Debt€ 55.38M€ 109.80M€ -40.65M€ -30.13M€ -43.27M
Total Liabilities€ 172.72M€ 244.07M€ 221.16M€ 204.19M€ 235.39M
Stockholders' Equity€ 214.16M€ 218.78M€ 204.64M€ 192.72M€ 183.73M
Cash Flow
Free Cash Flow€ -2.50M€ -18.77M€ 20.92M€ 20.17M€ 74.51M
Operating Cash Flow€ -1.73M€ -17.30M€ 22.90M€ 36.13M€ 90.98M
Investing Cash Flow€ 31.62M€ -129.39M€ 5.32M€ -20.34M€ -16.82M
Financing Cash Flow€ -34.41M€ -1.04M€ -4.98M€ -26.68M€ 65.33M
Currency in EUR

Pharming Group Earnings and Revenue History

Pharming Group Debt to Assets

Pharming Group Cash Flow

Pharming Group Forecast EPS vs Actual EPS